Open AccessTrends and Contributing Factors for Prescribing Antipsychotics in Newly Diagnosed Parkinson’s Disease Patients: A Population-Based Study
Author(s) -
Khalid Orayj
Publication year - 2021
Publication title -
risk management and healthcare policy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.828
H-Index - 22
ISSN - 1179-1594
DOI - 10.2147/rmhp.s313212
Subject(s) - medicine , quetiapine , risperidone , antipsychotic , cohort , dementia , pediatrics , psychiatry , psychosis , population , confounding , disease , schizophrenia (object oriented programming) , environmental health
Psychosis is very common in later stages of Parkinson's disease (PD) patients, but its prevalence in newly diagnosed patients is not rare. The use of antipsychotics in PD patients is complex given their association with worsening Parkinsonian motor symptoms and increased mortality rate. This study aims to examine factors that affect the use of antipsychotics in newly diagnosed PD patients and to identify changes in prescribing over time.